SmallCapPodcast.com
AGORACOM Small Cap TV AGORACOM Small-Cap Gold and Resources TV Chinese Small Cap Stock TV
LISTEN NOW LISTEN NOW LISTEN NOW
Nov 15, 2020 | by admin | Permalink

Agoracom interviews CEOs of small cap companies.

In this episode of the Small Cap CEO Interviews podcast, AGORACOM speaks with Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) CEO, Steven McAuley.

Sometimes, you just have to let the numbers speak for themselves. With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for … but then you see these numbers for the first half of the year:

Revenues $USD 1.7M vs $745,000 = 130% Gain
Patient Visits 12,400 vs 5,500 = 125% Gain

CBDT has now delivered growth in 4 successive financial reports (Q4, FY 2019, Q1 and Q2), so it is safe to say that superstar CEO Steve McAuley can officially claim victory on the turnaround he inherited in 2019.

But he is far from done.

Earlier today Empower announced it’s fresh out of the oven, newly acquired Kai Medical Laboratory Achieved Record Testing Volume Month in October and Has Already Signed Numerous New Contracts.

Despite officially acquiring KAI on October 5th, Empower was able to walk right into KAI and increase testing volume by 763% sequentially (vs September) to 1,375 units. While most companies need a couple of months to really start making changes within the operations of new acquisitions, McAuley hit the ground running and even.
How much revenue was generated from these record October tests? CEO McAuley gives us back of the napkin math to play with.

But he is far from done.

Just as Empower did with their clinics, Empower has aggressive growth strategies in place for KAI, including servicing new COVID-19 testing contracts for the:

* Film & television industry
* Banks
* Restaurants
* Tourism and ….

Supporting the Sun Valley Health COVID-19 RT-PCR and rapid antibody testing programs in the state of Arizona.
One, some or all of these should lead to even bigger numbers in November. In fact, we asked him if he was “concerned” that he may run out of capacity of 4,000 tests per day (a great concern to have). Wait until you hear his answer.

But just one more thing. Empower announced it: “has signed numerous new commercial testing contracts, the details of which will be provided in subsequent press releases.”

Somebody get out a calculator. It doesn’t take much to see that KAI has the potential to take Empower to a whole new level. Specifically, if you’re an investor in Well Health (WELL:TSX) and/or CloudMD (DOC:TSXV) you have to start taking a serious look at Empower as the next great potential health and wellness company. It’s already proven solid revenues and growth from its clinics, is expanding its telemedicine practice very nicely and now has the power to quickly generate significant enterprise level revenues from its newly acquired KAI medical diagnostics laboratory … which is already bearing fruit just 30 days after the acquisition.
Can McAuley pull it off? First consider what he has already accomplished after inheriting a catastrophe of a company in early 2019. Secondly, McAuley is Six Sigma certified under the quality initiative of legendary GE (General Electric) Chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history and turn it into significant growth through Q2 2020.

And if you MISSED Well Health and CloudMD, you really need to take a close look at Empower as the next great potential small cap health & wellness company.
Watch this amazing interview

Download This Episode

View Company Website

Visit Investor Relations Hub